Heme moiety of the malaria parasite — Drug Target

All drugs that target Heme moiety of the malaria parasite — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Antimalarial

Phase 2 pipeline (1)

• Artesunate vaginal insert · Frantz Viral Therapeutics, LLC · Antimalarial · Infectious Disease
  Artesunate is a derivative of artemisinin that targets the heme moiety of the malaria parasite, disrupting its 80-kDa protein.